Novartis Aktie
110,56
EUR
-0,50
EUR
-0,45
%
102,88
CHF
+2,46
CHF
+2,45
%
Werbung
Novartis Aktie Analyse
| 16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 14.12.21 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 11.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.11.21 | Novartis Buy | Jefferies & Company Inc. | |
| 04.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 26.10.21 | Novartis Buy | UBS AG | |
| 25.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.21 | Novartis Buy | UBS AG | |
| 14.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.10.21 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.10.21 | Novartis Buy | UBS AG | |
| 07.10.21 | Novartis Buy | Jefferies & Company Inc. | |
| 04.08.21 | Novartis Buy | UBS AG | |
| 27.07.21 | Novartis Overweight | Morgan Stanley | |
| 23.07.21 | Novartis Buy | UBS AG | |
| 22.07.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.21 | Novartis Buy | UBS AG | |
| 21.07.21 | Novartis Buy | Jefferies & Company Inc. | |
| 12.07.21 | Novartis Buy | Jefferies & Company Inc. | |
| 17.06.21 | Novartis buy | Deutsche Bank AG | |
| 15.06.21 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.06.21 | Novartis buy | UBS AG | |
| 04.06.21 | Novartis buy | Jefferies & Company Inc. | |
| 19.05.21 | Novartis buy | Deutsche Bank AG | |
| 14.05.21 | Novartis buy | UBS AG | |
| 11.05.21 | Novartis buy | Deutsche Bank AG | |
| 10.05.21 | Novartis buy | UBS AG | |
| 30.04.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.04.21 | Novartis buy | Deutsche Bank AG | |
| 28.04.21 | Novartis buy | Deutsche Bank AG | |
| 27.04.21 | Novartis buy | Jefferies & Company Inc. | |
| 27.04.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.04.21 | Novartis buy | UBS AG | |
| 23.03.21 | Novartis buy | Jefferies & Company Inc. | |
| 23.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.03.21 | Novartis buy | Deutsche Bank AG | |
| 09.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.03.21 | Novartis buy | Jefferies & Company Inc. | |
| 18.02.21 | Novartis buy | UBS AG | |
| 18.02.21 | Novartis buy | Deutsche Bank AG | |
| 16.02.21 | Novartis buy | Deutsche Bank AG | |
| 10.02.21 | Novartis buy | Deutsche Bank AG | |
| 09.02.21 | Novartis buy | Deutsche Bank AG | |
| 03.02.21 | Novartis buy | UBS AG | |
| 26.01.21 | Novartis buy | UBS AG | |
| 26.01.21 | Novartis overweight | Morgan Stanley | |
Werbung
Werbung